Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides

Journal of Endocrinology

Volumn 217, Issue 2, 2013, Pages 185-196

  Liu, Can ^a   Zhang, Mian ^a   Hu, Meng yue ^a   Guo, Hai fang ^a   Li, Jia ^a   Yu, Yun li ^a   Jin, Shi ^a   Wang, Xin ting ^a   Liu, Li ^a   Liu, Xiao dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ginseng total saponins (GTS); Ginsenosides; Glucagon like peptide 1(GLP1); Rb1; Type 2 diabetes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AZIDE; DIAZOXIDE; GINSENG TOTAL SAPONIN; GINSENOSIDE; GINSENOSIDE RB 1; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; NIFEDIPINE; PROGLUCAGON; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DYSLIPIDEMIA; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; GINSENOSIDES; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; STREPTOZOCIN;

EID: 84877319910     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0502     Document Type: Article

References (57)

1. Acitores A, González N, Sancho V, Valverde I & Villanueva-Pen~acarrilloML 2004 Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. Journal of Endocrinology 180 389-398. (doi:10.1677/joe.0. 1800389)
2. Attele AS, Wu JA & Yuan CS 1999 Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology 58 1685-1693. (doi:10.1016/S0006-2952(99)00212-9)
3. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS & Yuan CS 2002 Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51 1851-1858. (doi:10.2337/diabetes.51.6.1851)
4. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131-2157. (doi:10.1053/j.gastro.2007.03.054)
5. Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G & Delzenne NM 2005 Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinology 185 457-465. (doi:10.1677/joe.1.06100)
6. Chen GM, Hu N, Liu L, Xie SS, Wang P, Li J, Xie L,Wang GJ & Liu XD 2011 Pharmacokinetics of verapamil in diabetic rats induced by combination of high-fat diet and streptozotocin injection. Xenobiotica 41 494-500. (doi:10.3109/00498254.2011.558933)
7. Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D et al. 2008 A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149 2038-2047. (doi:10.1210/ en.2007-0966)
8. Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC 2011 Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141 150-156. (doi:10.1053/ j.gastro.2011.02.018)
9. Gao H, Wang X, Zhang Z, Yang Y, Yang J, Li X & Ning G 2007 GLP-1 amplifies insulin signaling by up-regulation of IRb, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine 32 90-95. (doi:10.1007/ s12020-007-9011-4)
10. Gribble FM, Williams L, Simpson AK & Reimann F 2003 A novel glucosesensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 1147-1154. (doi:10.2337/ diabetes.52.5.1147)
11. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiological Reviews 87 1409-1439. (doi:10.1152/physrev.00034.2006)
12. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M et al. 2007 Gut-expressed a-gustducin and taste receptors regulate secretion of glucagon-like peptide-1. PNAS 104 15069-15074. (doi:10.1073/pnas.0706890104)
13. Kim SH, Park KS 2003 Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacological Research 48 511-513. (doi:10.1016/S1043-6618(03)00189-0)
14. Kimura M,Waki I, Chujo T, Kikuchi T, Hiyama C, Yamazaki K & Tanaka O 1981a Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. Journal of Pharmacobio-Dynamics 4 410-417. (doi:10.1248/bpb1978.4.410)
15. Kimura M, Waki I, Tanaka O, Nagai Y & Shibata S 1981b Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. Journal of Pharmacobio-Dynamics 4 402-409. (doi:10.1248/bpb1978.4.402)
16. Knezevich E, Crnic T, Kershaw S & Drincic A 2012 Liraglutide-associated acute pancreatitis. American Journal of Health-System Pharmacy 69 386-389. (doi:10.2146/ajhp110221)
17. Li J, Wang P, Yu S, Zheng Z & Xu X 2012a Calcium entry mediates hyperglycemia-induced apoptosis through Ca2C/calmodulin-dependent kinase II in retinal capillary endothelial cells. Molecular Vision 18 2371-2379.
18. Li X, Chen Z, Jiang Z, Li Y & Zhang Y 2012b Zinc reverses glycinedependent inactivation of NMDARs in cultured rat hippocampal neurons. Science China. Life sciences 55 1075-1081. (doi:10.1007/ s11427-012-4421-9)
19. Lim W, Mudge KW & Vermeylen F 2005 Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). Journal of Agricultural and Food Chemistry 53 8498-8505. (doi:10.1021/jf051070y)
20. Liu H, Yang J, u F, Gao X,Ma X, Huang Y, Xu F, NiuW, Wang F, Mao Y et al. 2009 Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metabolism and Disposition 37 2290-2298. (doi:10.1124/dmd.109.029819)
21. Lu SS, Yu YL, Zhu HJ, Liu XD, Liu L, Liu YW, Wang P, Xie L, Wang GJ 2009 Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. Journal of Endocrinology 200 159-165. (doi:10.1677/JOE-08-0419)
22. Luo JZ & Luo L 2006 American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured b-cells. Evidence-Based Complementary and Alternative Medicine 3 365-372. (doi:10.1093/ecam/nel026)
23. Lupescu A, Jilani K, Zbidah M, Lang E & Lang F 2012 Enhanced Ca2C entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. Journal of Natural Products 75 1956-1961. (doi:10.1021/ np300611r)
24. Ma SW, Benzie IF, Chu TT, Fok BS, Tomlinson B & Critchley LA 2008 Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial. Diabetes, Obesity & Metabolism 10 1125-1127. (doi:10.1111/j.1463-1326.2008. 00858.x)
25. Odani T, Tanizawa H & Takino Y 1983a Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chemical & Pharmaceutical Bulletin 31 292-298. (doi:10.1248/ cpb.31.292)
26. Odani T, Tanizawa H & Takino Y 1983b Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chemical & Pharmaceutical Bulletin 31 1059-1066. (doi:10.1248/ cpb.31.1059)
27. Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, Yoo YB, Ko YC, Jun WT & Park HJ 2002 Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biological & Pharmaceutical Bulletin 25 457-460. (doi:10.1248/bpb.25.457)
28. Park MW, Ha J & Chung SH 2008a 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biological & Pharmaceutical Bulletin 31 748-751. (doi:10.1248/bpb.31.748)
29. Park S, Ahn IS, Kwon DY, Ko BS & Jun WK 2008b Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance b-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Bioscience, Biotechnology, and Biochemistry 72 2815-2823. (doi:10.1271/bbb.80205)
30. Ranganath LR 2008 Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. Journal of Clinical Pathology 61 401-409. (doi:10.1136/jcp.2006.043232)
31. Redondo A, Trigo MV, Acitores A, Valverde I, Villanueva-Pen~acarrillo ML 2003 Cell signalling of the GLP-1 action in rat liver. Molecular and Cellular Endocrinology 204 43-50. (doi:10.1016/S0303-7207(03)00146-1)
32. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM & Reaven GM 2000 A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49 1390-1394. (doi:10.1053/ meta.2000.17721)
33. Reimann F 2010 Molecular mechanisms underlying nutrient detection by incretin-secreting cells. International Dairy Journal 20 236-242. (doi:10.1016/j.idairyj.2009.11.014)
34. Reimann F, Gribble FM 2002 Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51 2757-2763. (doi:10.2337/ diabetes.51.9.2757)
35. Reimer RA, Darimont C, Gremlich S, Nicolas-Métral V, Rüegg UT & Macé K 2001 A human cellular model for studying the regulation of glucagonlike peptide-1 secretion. Endocrinology 142 4522-4528. (doi:10.1210/ en.142.10.4522)
36. Rotshteyn Y & Zito SW 2004 Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity. Journal of Ethnopharmacology 93 337-344. (doi:10.1016/ j.jep.2004.04.007)
37. Rouillé Y, Martin S & Steiner DF 1995 Differential processing of proglucagon by the subtillisin-like prohormone convertase PC2 and PC3 to generate either glucagon or glucagon-like peptide. Journal of Biological Chemistry 270 26488-26496. (doi:10.1074/jbc.270.44.26488)
38. SalehiM, Aulinger B, Prigeon RL & D'Alessio DA 2010 Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. Diabetes 59 1330-1337. (doi:10.2337/db09-1253)
39. Shang W, Yang Y, Zhou L, Jiang B, Jin H & Chen M 2008 Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. Journal of Endocrinology 198 561-569. (doi:10.1677/ JOE-08-0104)
40. Sotaniemi EA, Haapakoski E & Rautio A 1995 Ginseng therapy in noninsulin- dependent diabetic patients. Diabetes Care 18 1373-1375. (doi:10.2337/diacare.18.10.1373)
41. Srinivasan K, Viswanad B, Asrat L, Kaul CL & Ramarao P 2005 Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 52 313-320. (doi:10.1016/j.phrs.2005.05.004)
42. Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA, Ramalho-Santos J, Van Houten B & Schatten G 2011 Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE 6 e20914. (doi:10.1371/journal.pone.0020914)
43. Volonté MG, Yuln G, Quiroga P & Consolini AE 2004 Development of an HPLC method for determination of metabolic compounds in myocardial tissue. Journal of Pharmaceutical and Biomedical Analysis 35 647-653. (doi:10.1016/j.jpba.2004.02.002)
44. Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z & Vidgen E 2000 American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Archives of Internal Medicine 160 1009-1013. (doi:10.1001/archinte.160.7.1009)
45. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT et al. 2008 Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism, and Cardiovascular Diseases 18 46-56. (doi:10.1016/j.numecd. 2006.04.003)
46. Washida D, Kitanaka S 2003 Determination of polyacetylenes and ginsenosides in Panax species using high performance liquid chromatography. Chemical & Pharmaceutical Bulletin 51 1314-1317. (doi:10.1248/cpb.51.1314)
47. Xie HT, Wang GJ, Sun JG, Tucker I, Zhao XC, Xie YY, Li H, Jiang XL, Wang R, Xu MJ et al. 2005a High performance liquid chromatographic- mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 818 167-173. (doi:10.1016/j.jchromb. 2004.12.028)
48. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, A Rue P, Bell GI et al. 2005b Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochimica et Biophysica Acta 1740 319-325. (doi:10.1016/ j.bbadis.2004.10.010)
49. Xie JT, Mehendale S, Yuan CS 2005c Ginseng and diabetes. American Journal of Chinese Medicine 33 397-404. (doi:10.1142/ S0192415X05003004)
50. Xiong Y, Shen L, Liu KJ, Tso P, Wang G, Woods SC & Liu M 2010 Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 59 2505-2512. (doi:10.2337/db10-0315)
51. Yang CY, Wang J, Zhao Y, Shen L, Jiang X, Xie ZG, Liang N, Zhang L & Chen ZH 2010 Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components. Journal of Ethnopharmacology 130 231-236. (doi:10.1016/j.jep.2010.04.039)
52. Yokozawa T, Kobayashi T, Oura H & Kawashima Y 1985 Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chemical & Pharmaceutical Bulletin 33 869-872. (doi:10.1248/cpb.33.869)
53. Yoon SH, Han EJ, Sung JH & Chung SH 2007 Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. Biological & Pharmaceutical Bulletin 30 2196-2200. (doi:10.1248/bpb.30.2196)
54. Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B & Denaro M 1999 Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48 1026-1034. (doi:10.2337/diabetes.48.5.1026)
55. Yu YL, Lu SS, Yu S, Liu YC, Wang P, Xie L, Wang GJ & Liu XD 2009 Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats. Journal of Ethnopharmacology 124 444-449. (doi:10.1016/j.jep.2009.05.027)
56. Yu YL, Liu L, Wang XT, Liu X, Liu X, Xie L & Wang G 2010 Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochemical Pharmacology 79 1000-1006. (doi:10.1016/ j.bcp.2009.11.017)
57. Yun SN, Moon SJ, Ko SK, Im BO & Chung SH 2004 Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Archives of Pharmacal Research 27 790-796. (doi:10.1007/ BF02980150)